NYSE:DGXHealthcare
Quest Diagnostics (DGX) Is Up 7.1% After Q2 Results and Launch of New Diagnostic Tests – What's Changed
Quest Diagnostics reported second quarter 2025 results last week, highlighting a rise in sales to US$2.76 billion and net income to US$282 million, while also unveiling new diagnostic tests for the Oropouche virus and Alzheimer's disease.
Despite an impairment charge and slightly lowered annual guidance, the company's operational advances and new test launches appeared to drive optimism about future growth opportunities.
We'll explore how Quest's introduction of advanced diagnostic...